ethylcholine aziridinium has been researched along with (4-(m-chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium chloride in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fertel, R; Hadjiconstantinou, M; Neff, NH; Qu, ZX | 1 |
| Gaughan, C; Potter, PE; Thorne, B | 1 |
2 other study(ies) available for ethylcholine aziridinium and (4-(m-chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium chloride
| Article | Year |
|---|---|
Pharmacological characterization of muscarinic receptors mediating inhibition of adenylate cyclase activity in the rat retina.
Topics: (4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride; Acetylcholine; Adenylyl Cyclase Inhibitors; Animals; Arecoline; Aziridines; Carbachol; Choline; Colforsin; Cyclic AMP; Male; Oxotremorine; Rats; Rats, Inbred Strains; Receptors, Muscarinic; Retina | 1988 |
Modulation of hippocampal norepinephrine release by cholinergic agonists is altered by AF64A lesion.
Topics: (4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride; Animals; Aziridines; Binding Sites; Choline; Cholinergic Agonists; Cholinergic Antagonists; Electric Stimulation; Hippocampus; In Vitro Techniques; Male; Nicotine; Norepinephrine; Oxotremorine; Pirenzepine; Rats; Rats, Sprague-Dawley | 1997 |